Last Update 15 May 26
Fair value Decreased 5.85%ELK: Equity Raise And Biocarbon Project Will Support Future Upside
Elkem's updated analyst price target has shifted from NOK 33.29 to NOK 31.34, reflecting analysts' refreshed assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations.
What's in the News
- Elkem has filed a follow on equity offering of NOK 299.999997 million, offering 11,111,111 ordinary shares at NOK 27 per share through a rights offering (Key Developments).
- The company has completed a larger follow on equity offering of NOK 1.5b, issuing 55,555,555 common shares at NOK 27 per share via a subsequent direct listing (Key Developments).
- Elkem has been awarded NOK 87 million by Enova to develop industrial biocarbon solutions aimed at increasing renewable carbon use in Norwegian smelters. This is within a NOK 242 million project budget running to 2028 and targeting potential CO2 emission cuts of up to 0.5 million tonnes (Key Developments).
- The board has proposed changes to the articles of association to allow the nomination committee to consist of three or four members. Elections are generally held every two years, and responsibilities cover board and nomination committee recommendations and remuneration (Key Developments).
- At an extraordinary general meeting held on March 9, 2026, shareholders approved an amendment stating that Elkem's share capital is NOK 1,505,514,210 divided into 301,102,842 shares, each with a nominal value of NOK 5 (Key Developments).
Valuation Changes
- Fair Value: NOK 33.29 has shifted to NOK 31.34, indicating a modest reduction in the updated assessment.
- Discount Rate: The model discount rate has risen from 7.93% to 8.71%, a meaningful step up in the required return assumption.
- Revenue Growth: Forecast revenue growth has fallen from 19.37% to 7.22%, implying a much slower projected pace than before.
- Net Profit Margin: Expected net profit margin has increased from 7.16% to 10.51%, a substantial uplift in projected profitability per NOK of revenue.
- Future P/E: The future P/E multiple has moved from 13.20x to 12.11x, pointing to a slightly lower valuation multiple being used in the updated model.
Key Takeaways
- Strategic review and operational improvements, especially in China, may enhance competitiveness and increase earnings upon completion by year-end.
- Diverse geographical presence and R&D initiatives in sustainability could drive revenue growth and strong net margins amid global trade tensions.
- Global trade tensions, weak market demand, and strategic uncertainties threaten Elkem's revenues, margins, and market stability across key sectors.
Catalysts
About Elkem- Engages in the provision of advanced material solutions worldwide.
- Elkem's strategic review of the Silicones division and operational improvements, especially in China, are expected to enhance competitiveness and potentially increase earnings once the review is completed by year-end.
- The diverse geographical presence helps offset negative impacts from global trade tensions, suggesting that Elkem could maintain or increase revenue by leveraging its regional business model.
- Initiatives to supply the green transition, such as R&D in carbon capture, storage, and using biogenic materials, could enhance long-term revenue and net margins by meeting rising demand for sustainable products.
- Increased demand from sectors like automotive (driven by EV growth) and defense infrastructure projects (notably in Europe) may lead to higher sales volumes for Elkem's materials, positively impacting revenue.
- The focus on cost efficiency and operational discipline, such as completing maintenance during periods of low demand, should help maintain strong margins and improve profitability when market conditions improve.
Elkem Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Elkem's revenue will grow by 7.2% annually over the next 3 years.
- Analysts assume that profit margins will increase from 2.0% today to 10.5% in 3 years time.
- Analysts expect earnings to reach NOK 2.1 billion (and earnings per share of NOK 4.33) by about May 2029, up from NOK 331.0 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting NOK2.5 billion in earnings, and the most bearish expecting NOK910.6 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 12.1x on those 2029 earnings, down from 29.8x today. This future PE is lower than the current PE for the NO Chemicals industry at 26.3x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.71%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Global trade tensions and proposed tariffs are creating uncertainty, which could negatively impact trade flows and market demand, affecting Elkem's future revenues and margins.
- Weak market conditions and lower demand, particularly in China and the EU, are exerting downward pressure on prices for silicon and ferrosilicon, potentially reducing Elkem’s revenue and EBITDA margins.
- The Silicon Products division experienced reduced sales volumes and a drop in operating income, impacted by maintenance stops and power curtailment, which could further affect profitability if such disruptions continue.
- Declines in the global auto industry's consumer confidence and revised GDP forecasts signal economic slowdown, which might impact Elkem's critical markets like automotive and construction, thereby affecting future earnings.
- Strategic review and potential sale of the Silicones division, coupled with trade tensions, could hamper negotiations and result in unclear future income streams from this segment, impacting Elkem’s net margins and revenue stability.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of NOK31.34 for Elkem based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of NOK35.0, and the most bearish reporting a price target of just NOK26.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be NOK20.1 billion, earnings will come to NOK2.1 billion, and it would be trading on a PE ratio of 12.1x, assuming you use a discount rate of 8.7%.
- Given the current share price of NOK28.08, the analyst price target of NOK31.34 is 10.4% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Elkem?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.